potassium bromide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5650 | 7758-02-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Hyperammonaemia | 35.09 | 35.05 | 7 | 205 | 5225 | 63483585 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Status epilepticus | 75.71 | 51.20 | 18 | 266 | 12596 | 34944051 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Status epilepticus | 56.73 | 44.21 | 15 | 396 | 25026 | 79718951 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| KBroVet-CA1 | Pegasus Laboratories Inc. | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 4 | Enzyme | Ki | 4.05 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| CHEBI:32030 | CHEBI |
| K | PDB_CHEM_ID |
| CHEMBL1644030 | ChEMBL_ID |
| C039004 | MESH_SUPPLEMENTAL_RECORD_UI |
| 005010 | NDDF |
| C0071754 | UMLSCUI |
| DB01345 | DRUGBANK_ID |
| DB06715 | DRUGBANK_ID |
| 35903003 | SNOMEDCT_US |
| 421196003 | SNOMEDCT_US |
| 7758-02-3 | SECONDARY_CAS_RN |
| D01731 | KEGG_DRUG |
| 253877 | PUBCHEM_CID |
| 34299 | RXNORM |
| NOCODE | MMSL |
| OSD78555ZM | UNII |
Pharmaceutical products:
None